# DataMeds AI, Inc.: financial statements, quarterly

MEDS · Nasdaq · CIK 2030763 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/meds.md) · [Financials](/companies/meds/financials.md) · [Filings](/companies/meds/filings.md) · [Insiders](/companies/meds/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/meds/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [0.0](/filings/0001641172-25-024873.md) | [5.7](/filings/0001493152-25-024328.md) | [12.4 d](/filings/0001493152-26-012004.md) | [10.9](/filings/0001493152-26-024413.md) | [7.8](/filings/0001493152-26-038581.md) | [3.0](/filings/0001493152-25-024328.md) | [1.7 d](/filings/0001493152-26-012004.md) | [1.6](/filings/0001493152-26-024413.md) | [1.8](/filings/0001493152-26-038581.md) |
| Cost of revenue | $m | not reported | [0.0](/filings/0001641172-25-024873.md) | [5.2](/filings/0001493152-25-024328.md) | [11.2 d](/filings/0001493152-26-012004.md) | [10.2](/filings/0001493152-26-024413.md) | [7.3](/filings/0001493152-26-038581.md) | [2.8](/filings/0001493152-25-024328.md) | [9.5 d](/filings/0001493152-26-012004.md) | [1.4](/filings/0001493152-26-024413.md) | [1.6](/filings/0001493152-26-038581.md) |
| Gross profit | $m | not reported | [(0.0)](/filings/0001641172-25-024873.md) | [0.5](/filings/0001493152-25-024328.md) | [1.2 d](/filings/0001493152-26-012004.md) | [0.7](/filings/0001493152-26-024413.md) | [0.5](/filings/0001493152-26-038581.md) | [0.2](/filings/0001493152-25-024328.md) | [(7.9) d](/filings/0001493152-26-012004.md) | [0.2](/filings/0001493152-26-024413.md) | [0.2](/filings/0001493152-26-038581.md) |
| Operating income | $m | [(0.1)](/filings/0001641172-25-009565.md) | [(0.6)](/filings/0001641172-25-024873.md) | [(1.7)](/filings/0001493152-25-024328.md) | [(3.7) d](/filings/0001493152-26-012004.md) | [(31.3)](/filings/0001493152-26-024413.md) | [(5.5)](/filings/0001493152-26-038581.md) | [(31.5)](/filings/0001493152-25-024328.md) | [(25.4) d](/filings/0001493152-26-012004.md) | [(6.0)](/filings/0001493152-26-024413.md) | [(7.3)](/filings/0001493152-26-038581.md) |
| Interest expense | $m | [0.0](/filings/0001641172-25-009565.md) | [0.0](/filings/0001641172-25-024873.md) | [0.1](/filings/0001493152-25-024328.md) | [0.7 d](/filings/0001493152-26-012004.md) | [1.1](/filings/0001493152-26-024413.md) | [1.2](/filings/0001493152-26-038581.md) | [1.4](/filings/0001493152-25-024328.md) | [0.9 d](/filings/0001493152-26-012004.md) | [2.1](/filings/0001493152-26-024413.md) | [1.6](/filings/0001493152-26-038581.md) |
| Net income | $m | [(0.1)](/filings/0001493152-25-024328.md) | [(0.6)](/filings/0001493152-25-024328.md) | [(1.9)](/filings/0001493152-25-024328.md) | [(4.3) d](/filings/0001493152-26-012004.md) | [(32.4)](/filings/0001493152-26-038581.md) | [(6.7)](/filings/0001493152-26-038581.md) | [(34.3)](/filings/0001493152-25-024328.md) | [(27.9) d](/filings/0001493152-26-012004.md) | [(7.7)](/filings/0001493152-26-038581.md) | [(18.4)](/filings/0001493152-26-038581.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001641172-25-009565.md) | [(0.01)](/filings/0001641172-25-024873.md) | [(0.04)](/filings/0001493152-25-024328.md) | not reported | [(0.62)](/filings/0001493152-26-024413.md) | [(5.40)](/filings/0001493152-26-038581.md) | [(0.46)](/filings/0001493152-25-024328.md) | not reported | [(0.07)](/filings/0001493152-26-024413.md) | [(7.13)](/filings/0001493152-26-038581.md) |
| Basic EPS | $ per share | [0.00](/filings/0001641172-25-009565.md) | [(0.01)](/filings/0001641172-25-024873.md) | [(0.04)](/filings/0001493152-25-024328.md) | not reported | [(0.62)](/filings/0001493152-26-024413.md) | [(5.40)](/filings/0001493152-26-038581.md) | [(0.46)](/filings/0001493152-25-024328.md) | not reported | [(0.07)](/filings/0001493152-26-024413.md) | [(7.13)](/filings/0001493152-26-038581.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.0](/filings/0001641172-25-000612.md) | not reported | not reported | not reported | [1.0](/filings/0001493152-26-012004.md) | [2.5](/filings/0001641172-25-009565.md) | [0.4](/filings/0001641172-25-024873.md) | [4.2](/filings/0001493152-25-024328.md) | [0.0](/filings/0001493152-26-038581.md) | [0.1](/filings/0001493152-26-024413.md) | [2.5](/filings/0001493152-26-038581.md) |
| Current assets | $m | not reported | [0.3](/filings/0001641172-25-000612.md) | not reported | not reported | not reported | [15.2](/filings/0001493152-26-012004.md) | [16.6](/filings/0001641172-25-009565.md) | [13.5](/filings/0001641172-25-024873.md) | [12.8](/filings/0001493152-25-024328.md) | [2.8](/filings/0001493152-26-038581.md) | [2.8](/filings/0001493152-26-024413.md) | [5.6](/filings/0001493152-26-038581.md) |
| Total assets | $m | not reported | [0.3](/filings/0001641172-25-000612.md) | not reported | not reported | not reported | [57.3](/filings/0001493152-26-012004.md) | [58.1](/filings/0001641172-25-009565.md) | [54.2](/filings/0001641172-25-024873.md) | [52.8](/filings/0001493152-25-024328.md) | [30.5](/filings/0001493152-26-038581.md) | [30.1](/filings/0001493152-26-024413.md) | [32.8](/filings/0001493152-26-038581.md) |
| Current liabilities | $m | not reported | [2.9](/filings/0001641172-25-000612.md) | not reported | not reported | not reported | [38.0](/filings/0001493152-26-012004.md) | [46.2](/filings/0001641172-25-009565.md) | [42.4](/filings/0001641172-25-024873.md) | [32.7](/filings/0001493152-25-024328.md) | [29.8](/filings/0001493152-26-038581.md) | [32.2](/filings/0001493152-26-024413.md) | [39.4](/filings/0001493152-26-038581.md) |
| Total liabilities | $m | not reported | [3.2](/filings/0001641172-25-000612.md) | not reported | not reported | not reported | [50.6](/filings/0001493152-26-012004.md) | [53.6](/filings/0001641172-25-009565.md) | [53.3](/filings/0001641172-25-024873.md) | [46.0](/filings/0001493152-25-024328.md) | [42.9](/filings/0001493152-26-038581.md) | [45.2](/filings/0001493152-26-024413.md) | [52.3](/filings/0001493152-26-038581.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [11.5](/filings/0001493152-26-012004.md) | [24.1](/filings/0001641172-25-009565.md) | [10.1](/filings/0001641172-25-024873.md) | [12.6](/filings/0001493152-25-024328.md) | [12.6](/filings/0001493152-26-038581.md) | [12.6](/filings/0001493152-26-024413.md) | [12.6](/filings/0001493152-26-038581.md) |
| Current portion of debt | $m | not reported | [0.4](/filings/0001641172-25-000612.md) | not reported | not reported | not reported | [11.5](/filings/0001641172-25-009565.md) | [6.4](/filings/0001641172-25-009565.md) | [13.2](/filings/0001641172-25-024873.md) | [12.2](/filings/0001493152-25-024328.md) | [10.9](/filings/0001493152-26-038581.md) | [15.2](/filings/0001493152-26-024413.md) | [19.2](/filings/0001493152-26-038581.md) |
| Shareholders' equity | $m | [(0.0)](/filings/0001641172-25-000612.md) | [(2.9)](/filings/0001493152-26-012004.md) | [(3.0)](/filings/0001493152-25-024328.md) | [(3.1)](/filings/0001493152-25-024328.md) | [10.0](/filings/0001493152-25-024328.md) | [6.7](/filings/0001493152-26-038581.md) | [4.5](/filings/0001493152-26-038581.md) | [0.9](/filings/0001493152-26-038581.md) | [6.8](/filings/0001493152-25-024328.md) | [(12.4)](/filings/0001493152-26-038581.md) | [(15.1)](/filings/0001493152-26-038581.md) | [(19.5)](/filings/0001493152-26-038581.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [31.2](/filings/0001641172-25-009565.md) | [330 d](/filings/0001641172-25-024873.md) | [1,038 d](/filings/0001493152-25-024328.md) | [(2,624) d](/filings/0001493152-26-012004.md) | [(1,347)](/filings/0001493152-26-024413.md) | [(2,079) d](/filings/0001493152-26-038581.md) | [(1,135) d](/filings/0001493152-25-024328.md) | [(6,293) d](/filings/0001493152-26-012004.md) | [(3,413)](/filings/0001493152-26-024413.md) | [(2,894) d](/filings/0001493152-26-038581.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [44.7](/filings/0001641172-25-009565.md) | [45.9](/filings/0001641172-25-024873.md) | [48.4](/filings/0001493152-25-024328.md) | [51.9](/filings/0001493152-26-024413.md) | [1.2](/filings/0001493152-26-038581.md) | [74.4](/filings/0001493152-25-024328.md) | [105](/filings/0001493152-26-024413.md) | [2.6](/filings/0001493152-26-038581.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,061,919 at 2026-08-17, from the cover of the [10-Q filed 2026-08-17](/filings/0001493152-26-038581.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.